Vertical: HealthcareBase Year: 202323 Sections
Market Size (2023)
$7.84B
Projected (2032)
$17.03B
CAGR (2019–2032)
8.2%
Key Players
10+
This report covers Orthopaedic Soft Tissue Repair Market with forecasts from 2019 to 2032. 10 key companies are profiled.
The Orthopaedic Soft Tissue Repair Market market is projected to grow at a CAGR of 8.2% from 2019 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansINTRODUCTION
The rising sports-related injuries and increasing number of orthopaedic surgeries are driving the global Orthopaedic Soft Tissue Repair market. Furthermore, increasing innovative soft tissue repair implant devices and systems across the globe is boosting the growth of the market. Additionally, shortages of skilled orthopaedic surgeons and high costs of procedures and devices are restraining the growth of the global orthopaedic soft tissue repair market. However, a growing geriatric population, increasing funding and investment associated with orthopaedic soft tissue repair, and growing launches of soft tissue repair implant products will provide growth opportunities for the market in the future.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2023
Historical Period
2019 – 2022
Forecast Period
2024 – 2032
Primary Interviews
150+
Historical data (2019–2023) and forecast period (2023–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMichael Porter's Five Forces model is a framework to study the global orthopaedic soft tissue repair market. Strategic business managers trying to gain an edge over competing firms in the global orthopaedic soft tissue repair market can utilize this model to better comprehend the industry in which the firm operates. The components of each of the forces and the degree of impact of each component in the context of the global orthopaedic soft tissue repair market have been broken down and analysed.
PORTER'S FIVE FORCES ANALYSIs: Global orthopaedic soft tissue repair market
Threat of New Entrants
The threat of new entrants in the global orthopedic soft tissue repair market is moderate to low. The market is highly consolidated with a few major players dominating the landscape, which presents significant barriers to entry for newcomers. These barriers include the high capital investment required for research, development, and regulatory approval of orthopedic devices, particularly in highly regulated regions like the U.S. and Europe. Additionally, established companies already have strong brand recognition, well-developed distribution channels, and extensive intellectual property portfolios, which make it challenging for new entrants to gain a foothold. However, the rise of innovations, such as 3D-printed implants and bioresorbable materials, presents opportunities for niche players to enter the market with unique offerings, though they will still face substantial competition from existing industry giants.
BARGAINING POWER OF SUPPLIERS
The bargaining power of suppliers in the orthopedic soft tissue repair market is moderate. While there are multiple suppliers of raw materials like biologic substances, polymers, and metals for implants, the quality and reliability of these materials are crucial for the success of the devices. As a result, suppliers of specialized and high-quality materials may hold some power, especially if they offer unique or patented components that are integral to the function of advanced soft tissue repair products. However, the presence of multiple suppliers for most basic components reduces the overall bargaining power of suppliers. Large companies in the market can leverage their purchasing power to negotiate better terms, but they are still dependent on high-quality and timely delivery from these suppliers to maintain product standards.
Threat of Substitutes
The threat of substitutes in the orthopedic soft tissue repair market is moderate. While traditional treatments such as physical therapy, rest, and less invasive surgical procedures (e.g., sutures) exist, the rise of advanced repair technologies like biologic implants, 3D-printed solutions, and minimally invasive procedures provides significant alternatives. However, these substitutes often lack the same precision or long-term effectiveness as newer technologies, making them less attractive for patients requiring complex soft tissue repairs. Additionally, regenerative medicine (e.g., stem cell therapy) may emerge as a substitute in the future, offering non-surgical treatments for tissue regeneration. Despite these alternatives, the high effectiveness and precision of advanced soft tissue repair devices ensure that the threat of substitutes remains moderate, as they are often preferred for long-term, optimal results.
Bargaining Power of Buyers
The bargaining power of buyers in the orthopedic soft tissue repair market is relatively low to moderate, influenced by several factors. End-users, such as hospitals and orthopedic surgeons, typically do not have much leverage over large medical device manufacturers due to the specialized nature of the products and the high degree of technological advancement involved. These buyers often rely on the expertise of established companies to provide reliable, clinically tested, and FDA-approved devices. However, as more alternatives and product options become available in the market, buyers, particularly large healthcare systems, may gain some bargaining power by negotiating for better pricing or improved contract terms. Furthermore, with the increasing focus on cost containment and value-based healthcare, buyers in some regions may push for more cost-effective solutions, influencing market dynamics.
Intensity of Rivalry
The intensity of rivalry in the global orthopedic soft tissue repair market is high. The market is characterized by intense competition, driven by the need for continuous innovation and differentiation of products. Companies within the market are constantly striving to develop advanced devices that offer superior clinical outcomes, faster recovery times, and more precise surgical solutions. With the rapid pace of technological advancements, including the development of 3D-printed implants, biologic materials, and minimally invasive procedures, there is constant pressure to stay ahead of competitors. Additionally, the market is highly competitive due to the large number of both established companies and smaller players targeting niche segments. This leads to frequent product launches, extensive marketing efforts, and significant investments in research and development. The high costs associated with these innovations further intensify the competition, as companies must differentiate themselves to justify the price point and ensure broader market acceptance.
IMPACT OF COVID-19 on GLOBAL ORTHOPAEDIC SOFT TISSUE REPAIR MARKET
The impact of COVID-19 on the global orthopedic soft tissue repair market has been profound and multifaceted, disrupting both the demand for and supply of orthopedic treatments and devices. During the height of the pandemic, many healthcare systems were overwhelmed, forcing the postponement or cancellation of non-emergency surgeries, including elective orthopedic procedures such as soft tissue repairs. Hospitals and surgical centers, which were under immense pressure to allocate resources for COVID-19 patients, significantly reduced the volume of orthopedic surgeries being performed. As a result, there was a sharp decline in the demand for orthopedic implants, biologic materials, and other soft tissue repair devices, causing a temporary slowdown in the market. In addition, the disruption of global supply chains, triggered by lockdowns, international trade restrictions, and factory shutdowns, led to shortages in raw materials and finished products. This further exacerbated delays in both procedures and product delivery, contributing to extended waiting times and additional challenges for healthcare providers.
On the other hand, the pandemic also accelerated the demand for innovative, minimally invasive surgical techniques, which can reduce hospital stays and minimize the risk of infection—factors that became particularly important during the health crisis. These techniques, including arthroscopic procedures and biologic-based treatments, saw increased adoption as they offered safer, more efficient options for patients and healthcare providers. Additionally, the shift toward telemedicine and remote consultations, which became a norm during the pandemic, played a key role in raising public awareness about musculoskeletal health. This shift not only ensured continuity of care during periods of lockdown but also fostered greater recognition of orthopedic issues, indirectly driving demand for orthopedic care once the immediate effects of the crisis began to subside.
Furthermore, the pandemic highlighted the need for increased investment in healthcare infrastructure, with many countries focusing on upgrading medical facilities and improving the quality of surgical care. This focus on enhancing surgical safety protocols and ensuring better post-operative care has long-term implications for the orthopedic soft tissue repair market.
Market estimates by geography (2032)
InsightNA leads with $2.67T by 2032, while ROW is projected to grow fastest at a 7.2% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2019 | 2023 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $0.44M | $0.41M | $0.39M | -0.9% | 0% |
| Europe | $0.30M | $0.30M | $0.30M | -0.0% | 0% |
| Asia-Pacific | $0.18M | $0.21M | $0.24M | 2.2% | 0% |
| NA | $2.67T | $2.67T | $2.67T | N/A | 100% |
| ROW | $480.11M | $753.01M | $1.18B | 7.2% | 0% |
| Middle East and Africa | $0.40M | $0.42M | $0.43M | 0.7% | 0% |
| Total | $2.67T | $2.67T | $2.67T | 8.2% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$17.03B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Shoulder | $7.68B | 8.6% | 45% |
| Knee | $4.48B | 10.0% | 26% |
| Foot and Ankle | $2.81B | 5.8% | 17% |
| Hip | $2.05B | 7.2% | 12% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Orthopaedic Soft Tissue Repair Market covering market dynamics, competitive landscape, and strategic outlook.
The Orthopaedic Soft Tissue Repair Market market is projected to reach $17.03B by 2032, growing at 8.2% CAGR. The Shoulder segment holds the largest share.
INTRODUCTION
The rising sports-related injuries and increasing number of orthopaedic surgeries are driving the global Orthopaedic Soft Tissue Repair market. Furthermore, increasing innovative soft tissue repair implant devices and systems across the globe is boosting the growth of the market. Additionally, shortages of skilled orthopaedic surgeons and high costs of procedures and devices are restraining the growth of the global orthopaedic soft tissue repair market. However, a growing geriatric population, increasing funding and investment associated with orthopaedic soft tissue repair, and growing launches of soft tissue repair implant products will provide growth opportunities for the market in the future.
Rising Sports-Related Injuries
The rising incidence of sports-related injuries is significantly boosting the growth of the Global Orthopaedic Soft Tissue Repair Market. As sports participation continues to rise globally, especially among both professional athletes and recreational enthusiasts, the frequency of injuries to soft tissues such as ligaments, tendons, and muscles is increasing. High-impact and contact sports like football, basketball, soccer, and tennis are particularly associated with common soft tissue injuries, including ACL tears, rotator cuff injuries, and Achilles tendon ruptures. According to the National Safety Council, in 2023, 3.7 million individuals received treatment in emergency departments for injuries related to sports and recreational equipment. The activities most commonly linked to these injuries include exercise, cycling, and basketball. Moreover, Australian Institute of Health and Welfare, in 2021–22, the sports leading to the highest number of injury-related hospitalisations were those involving wheels and various forms of football. Cycling accounted for approximately 8,600 hospitalisations, followed by Australian rules football (4,300), roller sports (4,100), and motorized wheeled sports (3,800). Furthermore, according to the U.S. Bureau of Labor Statistics, there were 5,283 fatal work-related injuries in the United States in 2023, marking a 3.7% decrease from the 5,486 fatalities reported in 2022. The fatality rate for work injuries was 3.5 deaths per 100,000 full-time equivalent (FTE) workers, a decrease from 3.7 in 2022. This data comes from the Census of Fatal Occupational Injuries (CFOI).
In conclusion, the increasing prevalence of sports-related injuries is driving substantial growth in the Global Orthopaedic Soft Tissue Repair Market. As more individuals engage in sports and recreational activities, particularly high-impact and contact sports, the incidence of soft tissue injuries such as ligament tears, tendon ruptures, and muscle strains continues to rise. With millions seeking treatment annually for these injuries, the demand for effective orthopaedic interventions is expected to remain strong. The statistics from various health organizations highlight the significant impact of these injuries, underscoring the need for improved prevention, treatment, and rehabilitation strategies to address this growing healthcare challenge.
Increasing number of Orthopaedic Surgeries
The increasing number of orthopedic surgeries is significantly driving the growth of the global orthopedic soft tissue repair market. As the global population ages and as sports-related injuries, degenerative conditions, and trauma cases rise, there is a higher demand for orthopedic procedures, particularly those involving soft tissue repair. Conditions such as rotator cuff tears, ligament injuries, and meniscal tears require advanced soft tissue repair techniques, fueling the demand for specialized products like sutures, anchors, and biologics. According to a study published by Elsevier in November 2021, a survey was completed by 140 members of the ACL Special Interest Group (SG). Fifty percent of the respondents were from Europe, 29% from the USA, 15% from the Asia-Pacific region, and the remaining 6% from Latin America, the Middle East, New Zealand, and Africa. A majority (92%) of participants believe non-operative management is not suitable for ACL tears in high-level athletes, whereas a similar proportion (92%) agree that non-operative treatment is appropriate for lower-impact athletes.
Moreover, as per the American Academy of Physical Medicine and Rehabilitation study published in December 2023, the medial collateral ligament (MCL) is injured in at least 42% of ligamentous knee injuries, with isolated MCL injuries accounting for 29% of these cases. In the U.S., the incidence of MCL injuries is 0.24 per 1,000 people, which translates to approximately 74,000 injuries each year. MCL sprains are the most common knee injury among high school athletes. In young athletes, one study found that females have a higher rate of MCL injuries at the high school level, while males experience a higher rate at the college level.
Further, according to the World Health Organization reported in July 2022, low back pain is the leading contributor to the global burden of musculoskeletal conditions, affecting 570 million people worldwide and accounting for 7.4% of global Years Lived with Disability (YLDs). Other significant contributors include fractures (440 million people, 26 million YLDs), osteoarthritis (528 million people, 19 million YLDs), neck pain (222 million people, 22 million YLDs), amputations (180 million people, 5.5 million YLDs), rheumatoid arthritis (18 million people, 2.4 million YLDs), gout (54 million people, 1.7 million YLDs), and other musculoskeletal conditions (453 million people, 38 million YLDs).
In conclusion, the growing demand for orthopedic soft tissue repair is being driven by an aging global population, an increase in sports-related injuries, and a rise in degenerative conditions and trauma cases. Key injuries such as rotator cuff tears, ligament damage, and meniscal tears are fueling the need for advanced repair techniques and specialized products like sutures, anchors, and biologics. Studies show that non-operative treatments are often deemed unsuitable for high-level athletes but are considered effective for lower-impact athletes. With injuries like MCL sprains and low back pain contributing significantly to the global burden of musculoskeletal conditions, the demand for orthopedic soft tissue repair procedures is expected to continue growing, highlighting the critical need for innovative solutions in this market.
Increasing Innovative soft tissue repair Implant devices and systems
The increasing innovation in soft tissue repair implant devices and systems is significantly accelerating the growth of the global orthopedic soft tissue repair market. Advancements in materials, design, and technology have led to the development of more effective, durable, and minimally invasive solutions for repairing torn ligaments, tendons, and cartilage. Innovations such as bioabsorbable sutures, 3D-printed implants, and advanced suture anchors are enhancing the precision and efficiency of soft tissue repair surgeries.
April 2022: CoNextions Inc. has announced that its CoNextions TR Tendon Repair System has received FDA 510(k) clearance, with plans for a commercial launch in May 2022. Designed to address traumatic tendon lacerations in the hand, wrist, and forearm, the novel system offers a stronger, faster, and smoother repair compared to conventional suture methods. Supported by a clinical trial involving 90 patients, the system has demonstrated a lower rate of treatment failure and rupture. CoNextions is positioning the CoNextions TR device as an advanced alternative for orthopedic surgeons, both in the U.S. and internationally, continuing its commitment to improving patient outcomes and surgical practices in soft-tissue repair.
May 2022: Paragon 28, a leading orthopedic medical device company, has launched the TenoTac 2.0 Soft Tissue Stabilization System to enhance hammertoe and soft tissue repair procedures. The innovative TenoTac 2.0 features an optimized titanium threaded implant that allows for better capture of soft tissue, streamlined tensioning, and improved fit to the bony surface. This system is designed to provide more precise fixation of soft tissue to bone, particularly for treating contractures of the lesser toes. The new design gives surgeons greater control and precision, improving patient outcomes. With this launch, Paragon 28 expands its portfolio of soft tissue repair products, focusing on delivering advanced solutions in the hammertoe market.
In conclusion, ongoing innovations in soft tissue repair devices are driving significant growth in the global orthopedic market.
The growing geriatric population is significantly contributing to the expansion of the global orthopedic soft tissue repair market. As the global population ages, there is an increasing prevalence of age-related musculoskeletal conditions such as osteoarthritis, tendonitis, rotator cuff tears, and ligament injuries. Older adults are more susceptible to these soft tissue injuries due to the natural degeneration of connective tissues, decreased bone density, and reduced healing capacity with age. This demographic shift is creating a higher demand for orthopedic treatments, particularly those focused on repairing and regenerating soft tissues. As a result, there are flourishing opportunities for companies to develop specialized products, such as advanced biologics, grafts, and minimally invasive surgical tools, tailored to the needs of the elderly. Furthermore, the increasing geriatric population in North America, Europe, and Asia-Pacific will create lucrative growth opportunities in the upcomin years s per merica’s Health Rankings, approximately 58 million adults ages 65 and older were living in the US in 2022, and this number was projected to grow nearly 22% in the US in 2040. According to the European Commission, there were 448.8 million people, and more than one fifth of them were aged 65 years and over in Europe.
As per the Asia-Pacific Report on Population Ageing 2022, there were approximately 670 million people aged 60 or older in Asia-Pacific in 2022. Also, it has been estimated that the number will double to approximately 1.3 billion people by 2050 in Asia-Pacific. Additionally, geriatric patients often require more personalized care and longer rehabilitation, driving demand for innovative solutions that promote faster healing and improved functional outcomes. This growing population segment is thus becoming a key driver for the orthopedic soft tissue repair market, with companies increasingly focusing on this demographic to meet their healthcare needs. Increasing funding and investment in orthopaedic soft tissue repair are playing a pivotal role in accelerating the growth of the global market. As demand for advanced treatments and technologies rises, investors are channeling significant capital into research, development, and commercialization of innovative soft tissue repair solutions. This influx of funding is driving the creation of cutting-edge products, such as bioresorbable implants, tissue-engineered grafts, and regenerative biologics like stem cell therapies, which aim to improve healing and reduce recovery times for patients.
Additionally, financial backing is enabling companies to explore minimally invasive surgical techniques, which are becoming increasingly popular for soft tissue injuries due to their reduced risk of complications and quicker recovery periods. ▪ April 2024: Integrity Orthopaedics, Inc. (US), a leader in next-generation soft tissue repair solutions, has successfully completed its Series B financing round, raising USD 20.6 million. The round was co-led by Piper Sandler Merchant Banking and an undisclosed existing investor. The company plans to use the capital to accelerate the U.S. commercial launch of its initial product focused on the rotator cuff repair market. Integrity Orthopaedics aims to revolutionize soft tissue repair with its patented technology, which promises stronger surgical repairs and enhanced long-term healing. This funding milestone marks a significant step in the company’s efforts to drive innovation and improve patient outcomes in orthopedic soft tissue surgeries. ▪ March 2023: Penn State College of Medicine – Rotator cuff injuries, the second leading cause of musculoskeletal pain after lower back pain, are increasingly prevalent, especially among individuals over 80, who face a 64% risk of sustaining such an injury. These injuries often result in incomplete healing, leading to secondary damage to adjacent muscles and impacting overall function.
To better understand the effects of rotator cuff injuries and surgical repair on muscle composition, researchers from Penn State University and the University of Oregon have been awarded a USD 2.3 million grant from the National Institutes of Health (NIH). The five-year research project, funded by the Stephen I. Katz Early- Stage Investigator Research Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, aims to shed light on the complex changes in muscle structure and function post-injury and repair, ultimately contributing to more effective treatments and outcomes for rotator cuff injuries. Moreover, partnerships between venture capitalists, medical device companies, and academic institutions are fostering collaborative efforts to address unmet needs in orthopaedic surgery, leading to the introduction of highly specialized and effective treatments. As a result, the growing investment in this field is not only boosting product innovation but also expanding access to advanced care, thereby fueling the continued growth of the global orthopaedic soft tissue repair market. The growing launch of soft tissue repair implant products is playing a pivotal role in boosting the growth of the Global Orthopaedic Soft Tissue Repair Market.
Innovations in biologically active implants, designed to enhance tissue regeneration, reduce recovery times, and improve surgical outcomes, are gaining momentum. These advancements are meeting the increasing demand for effective solutions for conditions such as rotator cuff tears, Achilles tendon ruptures, and tendinopathy. As more companies launch groundbreaking products with clinical backing, the market is seeing a surge in both technological improvements and adopt
Shortages of Skilled Orthopaedic Surgeon
The shortage of skilled orthopedic surgeons is a significant challenge that is restraining the growth of the global orthopedic soft tissue repair market. As the demand for orthopedic procedures continues to rise, particularly with the aging global population and increased incidence of sports-related injuries, the limited number of trained professionals is becoming a critical bottleneck. Many regions, especially in rural or underserved areas, face shortages of qualified surgeons capable of performing complex soft tissue repair surgeries. For instance, according to a 2021 report from the Association of American Medical Colleges, the U.S. is projected to face a shortage of 37,800 to 124,000 physicians by 2034, impacting both primary and specialty care including orthopaedic surgery. This workforce shortage is anticipated to affect all areas of orthopedics, exacerbating challenges in the healthcare system.
Moreover, according to the AMN Healthcare (U.S.) reported in November 2019, a looming shortage of orthopedic surgeons is becoming a critical concern as the demand for orthopedic procedures rises. The Centers for Disease Control and Prevention (CDC) reports a sharp increase in hip replacements among individuals aged 45 and older, from 138,700 to 310,800 over the past decade, reflecting the growing need for orthopedic specialists. This demand is largely driven by an aging population, which requires more treatments for conditions common in older adults. The Association of American Medical Colleges (AAMC) projects a shortage of up to 122,000 physicians by 2032, with up to 67,000 of those being specialists, including a shortage of around 23,000 surgeons. This gap in the healthcare workforce could hinder patient access to critical orthopedic care, further straining the healthcare system.
This shortage not only limits patient access to advanced treatments but also places additional strain on healthcare systems, leading to longer wait times and potentially lower quality of care. As a result, despite the availability of innovative repair devices and systems, the inability to effectively deploy these technologies due to a lack of skilled professionals hinders the broader adoption of these solutions and slows market growth. Moreover, the shortage may also impact the training and expertise required to handle increasingly sophisticated surgical tools and techniques, further limiting the potential for market expansion.
High Cost of Procedures and Devices
The high cost of procedures and medical devices is a significant restraint on the growth of the global orthopedic soft tissue repair market. Advanced surgical techniques and cutting-edge devices, such as specialized implants, biologic materials, and 3D-printed solutions, are often much more expensive than traditional treatments. This makes them inaccessible to many patients, especially those without comprehensive insurance coverage or those in regions with limited healthcare resources. The financial burden on patients and healthcare systems can also lead to delays in treatment, worsening conditions, and the need for more complex procedures. In some cases, patients may turn to more affordable, yet less effective, alternatives, which could compromise long-term recovery and increase the risk of complications.
For healthcare providers, the high cost of acquiring and implementing these advanced devices can deter them from offering the latest treatments, particularly in areas with low reimbursement rates or limited public funding. The expense associated with these procedures also contributes to longer wait times, as hospitals prioritize more routine cases over specialized orthopedic surgeries. This financial barrier reduces the widespread adoption of new technologies, limiting access to improved patient outcomes and recovery options. Unless device costs decrease or insurance coverage increases, the orthopedic soft tissue repair market will struggle to reach its full potential, particularly in emerging markets and lower-income regions.
The growing geriatric population is significantly contributing to the expansion of the global orthopedic soft tissue repair market. As the global population ages, there is an increasing prevalence of age-related musculoskeletal conditions such as osteoarthritis, tendonitis, rotator cuff tears, and ligament injuries. Older adults are more susceptible to these soft tissue injuries due to the natural degeneration of connective tissues, decreased bone density, and reduced healing capacity with age. This demographic shift is creating a higher demand for orthopedic treatments, particularly those focused on repairing and regenerating soft tissues. As a result, there are flourishing opportunities for companies to develop specialized products, such as advanced biologics, grafts, and minimally invasive surgical tools, tailored to the needs of the elderly.
Furthermore, the increasing geriatric population in North America, Europe, and Asia-Pacific will create lucrative growth opportunities in the upcoming years. As per America’s Health Rankings, approximately 58 million adults ages 65 and older were living in the US in 2022, and this number was projected to grow nearly 22% in the US in 2040. According to the European Commission, there were 448.8 million people, and more than one fifth of them were aged 65 years and over in Europe. As per the Asia-Pacific Report on Population Ageing 2022, there were approximately 670 million people aged 60 or older in Asia-Pacific in 2022. Also, it has been estimated that the number will double to approximately 1.3 billion people by 2050 in Asia-Pacific.
Additionally, geriatric patients often require more personalized care and longer rehabilitation, driving demand for innovative solutions that promote faster healing and improved functional outcomes. This growing population segment is thus becoming a key driver for the orthopedic soft tissue repair market, with companies increasingly focusing on this demographic to meet their healthcare needs.
Increasing funding and investment associated with Orthopaedic Soft Tissue Repair
Increasing funding and investment in orthopaedic soft tissue repair are playing a pivotal role in accelerating the growth of the global market. As demand for advanced treatments and technologies rises, investors are channeling significant capital into research, development, and commercialization of innovative soft tissue repair solutions. This influx of funding is driving the creation of cutting-edge products, such as bioresorbable implants, tissue-engineered grafts, and regenerative biologics like stem cell therapies, which aim to improve healing and reduce recovery times for patients. Additionally, financial backing is enabling companies to explore minimally invasive surgical techniques, which are becoming increasingly popular for soft tissue injuries due to their reduced risk of complications and quicker recovery periods.
April 2024: Integrity Orthopaedics, Inc. (US), a leader in next-generation soft tissue repair solutions, has successfully completed its Series B financing round, raising USD 20.6 million. The round was co-led by Piper Sandler Merchant Banking and an undisclosed existing investor. The company plans to use the capital to accelerate the U.S. commercial launch of its initial product focused on the rotator cuff repair market. Integrity Orthopaedics aims to revolutionize soft tissue repair with its patented technology, which promises stronger surgical repairs and enhanced long-term healing. This funding milestone marks a significant step in the company’s efforts to drive innovation and improve patient outcomes in orthopedic soft tissue surgeries.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Orthopaedic Soft Tissue Repair Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Company Headquarters: Melsungen, Germany Founded: 1839 Workforce: ~ 66,234 Company Working: B. Braun SE (B. Braun) is a manufacturer and supplier of healthcare products for hospitals, surgical units, private practices (medical care and doctors’ offices), and extracorporeal blood treatments. Its key business areas include clinical nutrition, urinary care, infection prevention, infusion therapy, diabetes care, neurosurgery, extracorporeal blood treatment, IV drugs, orthopedics, spine, and wound care, among others. The company operates through four major business segments, namely, hospital care, Aesculap, outpatient market, and B. Braun Avitum. With these four divisions, the company offers over 5,000 products, out of which it manufactures 95% of the products. Geographically it operates in 64 countries across Europe, Asia-Pacific, Latin America, and the Middle East and Africa. It operates through various subsidiaries such as B. Braun Medical Inc., Aesculap AG, and B. Braun Avitum France SAS, among others.
Company Headquarters: Warsaw, Indiana, (US) Founded: 1927 Workforce: 19,000+ Company Working: Zimmer develops, produces, and markets musculoskeletal healthcare products. It is a leading brand in providing customized joint and bone healthcare solutions. It offers products related to orthopedics, healthcare, medical instruments, medical technology, surgical instruments, medical supplies, medical devices, innovation, and signature solutions. The company is present in all major markets and holds significant market share in the global tissue engineering market.
Company Headquarters: Michigan, US Founded: 1941 Workforce: ~51,000 Company Working: Stryker is engaged in developing, manufacturing, and marketing specialty surgical and medical products. Its products include implants, biologics, surgical, neurologic, ear, throat, interventional pain equipment, endoscopic, surgical navigation, communications, and digital imaging systems. The company also offers products for patient handling and emergency medical equipment. It operates through three major segments: medical & surgical equipment (MedSurg), orthopedics, and neurotechnology & spine. Stryker has been focused on providing automation solutions in its product portfolio. It has a presence in over 75 countries across the globe.
Company Headquarters: Massachusetts, US Founded: 1979 Workforce: ~36,000 Company Working: Boston Scientific Corporation is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In addition, Boston Scientific serves hospitals, clinics, outpatient facilities and medical offices across the world. Boston Scientific Corporation's manufacturing facilities are located across Malaysia, the US, and Ireland. Apart from this, it has a presence in countries like Japan, the Netherlands, France, Poland, India, China, Turkey, South Africa, and Singapore.
23 interactive charts drawn from the Orthopaedic Soft Tissue Repair Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Orthopaedic Soft Tissue Repair Market By Region
Global Orthopaedic Soft Tissue Repair Market By Specialty Orthopaedic Clinics
Global Orthopaedic Soft Tissue Repair Market By Ambulatory Surgical Centers (Ascs)
Global Orthopaedic Soft Tissue Repair Market By Hospitals
Global Orthopaedic Soft Tissue Repair Market By Tibial Tendon Dysfunction
Global Orthopaedic Soft Tissue Repair Market By Achilles Tendon Ruptures
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
